Premarket Mover: Immuneering Corp (IMRX) Up 3.89%

Immuneering Corp (IMRX) has risen Wednesday morning, with the stock adding 3.89% in pre-market trading to 2.67. IMRX's short-term technical score of 2 indicates that the stock has traded less bullishly over the last month than 98% of stocks on the market. In the Biotechnology industry, which ranks 102 out of 146 industries, Immuneering Corp ranks higher than 1% of stocks. Immuneering Corp has fallen 61.06% over the past month, closing at $6.58 on February 21. During this period of time, the stock fell as low as $1.91 and as high as $7.68. IMRX has an average analyst recommendation of Buy. The company has an average price target of $16.86.

IMRX has an Overall Score of 33. Find out what this means to you and get the rest of the rankings on IMRX!

See Full IMRX Report

Immuneering Corp has a Long-Term Technical rank of 1. This means that trading over the last 200 trading days has placed the company in the lower half of stocks with 99% of the market scoring higher. In the Biotechnology industry which is number 67 by this metric, IMRX ranks better than 67% of stocks.

Important Dates for Investors in IMRX:

-Immuneering Corp is set to release earnings on 2024-05-02. Over the last 12 months, the company has reported EPS of $-1.87. -We do not have a set dividend date for Immuneering Corp at this time. Click Here To Get The Full Report on Immuneering Corp (IMRX)